Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

Meet CPI: the UK not-for-profit dedicated to de-risking innovation.

Will the antibiotic apocalypse kill us all?

Sitting Down With… Brian Henry, Vice President of Drug Product Design, Pharmaceutical Sciences department at Pfizer.

Continuous wet granulation will be the star of a new UK facility, which stems from a collaboration between CPI, GSK and AstraZeneca.

The tablet press is a pharma manufacturing facility staple, but today’s systems need to be faster, more reliable and more flexible than ever before.

By simulating processes in a digital twin of a facility, changes can be safely tested before application in the real world.

Dry granulation offers several advantages to manufacturers and it’s now attracting more attention with the push towards continuous manufacturing.

Delays arising from formulation issues are commonplace in the industry. It’s time to start thinking about the problem earlier.

Nominations are now open for The Medicine Maker 2020 Power List.